Today: 8 April 2026
Netflix stock ends higher as Trump steps back from Warner Bros battle, then slips after hours
5 February 2026
1 min read

Netflix stock ends higher as Trump steps back from Warner Bros battle, then slips after hours

New York, Feb 5, 2026, 17:27 EST — After-hours

  • Netflix ended the day up 0.9%, then slipped roughly 0.4% in after-hours trading
  • Trump said he won’t step into Netflix’s dispute with Paramount Skydance over Warner Bros Discovery
  • Investors have their eyes on the U.S. antitrust review and the February 20 deadline linked to Paramount’s offer

Netflix (NFLX.O) shares ticked up 0.9% to finish at $80.87 on Thursday, then slipped roughly 0.4% to $80.52 in after-hours trading, which extends beyond the 4 p.m. close. The stock reaction came after U.S. President Donald Trump said he would not get involved in Netflix’s dispute with Paramount Skydance over Warner Bros Discovery. Public

The comment matters because the Warner Bros process has become as much a regulatory saga as a deal. Trump stepping aside cuts one political factor out, but it doesn’t alter the main obstacle: the U.S. Justice Department’s review, which could drag on for months and end with conditions, delays, or even a block.

Traders have zeroed in on headlines about the proposed acquisition, causing the stock to jump with every fresh update. As a result, Netflix finds itself in an unusual position: company performance takes a backseat while Washington scrutinizes the deal’s structure and timing.

On Tuesday, U.S. senators grilled Netflix co-CEO Ted Sarandos during a hearing focused on whether the deal would stifle competition and limit choices for consumers and workers. Senator Mike Lee dubbed Netflix “the one platform to rule them all,” while Sarandos described the fight for viewers’ attention as a “zero-sum game.” Reuters

Netflix closed higher despite a sharp sell-off on Wall Street, where the Nasdaq dropped 1.59% and the S&P 500 fell 1.23%. Investors fretted over hefty AI spending projections and softer U.S. labor data. Reuters

The stock showed volatile moves throughout the week. It dropped 3.4% on Tuesday but bounced back over the following two days, closing Thursday at $80.87. Investing.com

According to an SEC filing, director Reed Hastings sold shares on Feb. 2 by exercising options under a Rule 10b5-1 plan, a pre-set trading arrangement for insiders. The sale happened in three batches, with weighted average prices of $83.2223, $84.0947, and $84.9551, the document revealed. SEC

Netflix has put forward an $82.7 billion bid to acquire Warner Bros Discovery’s streaming and studio businesses. At the same time, Paramount Skydance is pushing a rival hostile offer. Warner Bros shareholders are set to vote on the Netflix deal in March. Paramount has also extended its tender-offer deadline to Feb. 20, according to an earlier Reuters report. Reuters

The risk points one way if the process sours. Regulators might push for concessions that undercut the deal’s value or drag out the timeline, leaving shares in limbo. On top of that, fresh political noise could shift the odds once more.

Investors are set to focus on any new cues from antitrust regulators, updates on the Warner Bros process filings, and possible shifts in bidder terms ahead of the Feb. 20 deadline, all leading into Friday’s session.

Stock Market Today

  • Jim Cramer's Charitable Trust swaps Bristol Myers Squibb for Johnson & Johnson
    April 8, 2026, 12:51 PM EDT. Jim Cramer's Charitable Trust is exiting its position in Bristol Myers Squibb (BMY), selling 1,100 shares at about $58.94 and initiating a new stake in Johnson & Johnson (JNJ) with 150 shares around $237.65. The trust will now hold approximately 1% of its portfolio in JNJ. Bristol Myers faced challenges in early 2025, including tariff concerns and a failed trial for Cobenfy, resulting in modest gains despite a recent 30% rally. Johnson & Johnson, with a stronger long-term performance gaining 58% over a year, offers a diversified revenue base of $94 billion, focusing on oncology, immunology, neuroscience, and medical devices. The recent $14.6 billion acquisition of Intra-Cellular Therapies enhances JNJ's schizophrenia drug portfolio, positioning it well against competitors. The strategic shift reflects a preference for stable commercial prospects over binary clinical outcomes.

Latest article

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

8 April 2026
Zevenbergen Capital increased its Alphabet Class A share holdings by 27.4% in Q4, while Lombard Odier and Empirical Wealth Management reduced their Class C positions, according to April 7 filings. Alphabet will report first-quarter results on April 29. GOOG and GOOGL traded near $304 before Wednesday’s U.S. open. The filings reflect holdings as of December 31 and may not show current positions.
Atlassian stock slides after Q2 results as CEO rejects ‘software is dead’ AI fears
Previous Story

Atlassian stock slides after Q2 results as CEO rejects ‘software is dead’ AI fears

Amazon stock price slides after-hours on $200B AI spending forecast as AI stocks wobble
Next Story

Amazon stock price slides after-hours on $200B AI spending forecast as AI stocks wobble

Go toTop